Cue Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.

About CUE

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). 

CEO
Usman Azam
CEOUsman Azam
Employees
41
Employees41
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2014
Founded2014
Employees
41
Employees41

CUE Key Statistics

Market cap
22.12M
Market cap22.12M
Price-Earnings ratio
-0.53
Price-Earnings ratio-0.53
Dividend yield
Dividend yield
Average volume
1.19M
Average volume1.19M
High today
$0.2698
High today$0.2698
Low today
$0.2303
Low today$0.2303
Open price
$0.245
Open price$0.245
Volume
724.92K
Volume724.92K
52 Week high
$1.75
52 Week high$1.75
52 Week low
$0.2302
52 Week low$0.2302

Stock Snapshot

Cue Biopharma(CUE) stock is priced at $0.24, giving the company a market capitalization of 22.12M. It carries a P/E multiple of -0.53.

As of 2025-12-25, Cue Biopharma(CUE) stock has fluctuated between $0.23 and $0.27. The current price stands at $0.24, placing the stock +5.5% above today's low and -10.0% off the high.

Cue Biopharma(CUE) shares are trading with a volume of 724.92K, against a daily average of 1.19M.

During the past year, Cue Biopharma(CUE) stock moved between $0.23 at its lowest and $1.75 at its peak.

During the past year, Cue Biopharma(CUE) stock moved between $0.23 at its lowest and $1.75 at its peak.

CUE News

TipRanks 5d
Cue Biopharma Announces $10 Million Public Equity Offering

Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...

TipRanks 6d
Cue Biopharma prices 35.7M shares at 28c in underwritten public offering

Cue Biopharma (CUE) announced the pricing of an underwritten public offering of 35,714,286 shares of its common stock and accompanying common stock warrants to...

People also own

Based on the portfolios of people who own CUE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.